Pierre V. Trân
Corporate Officer/Principal bei Duke University
Profil
Dr. Pierre V.
Trân, MD, is Chief Medical Officer at Euthymics Bioscience, Inc., an Assistant Consulting Professor at Duke University, a Member at American Psychiatric Association, and a Member at Society of Biological Psychiatry.
Dr. Trân was previously employed as Chief Medical Officer & VP-Clinical Development by Cortex Pharmaceuticals, Inc., Chief Medical Officer & Senior Vice President by XenoPort, Inc., Global Medical Director-Joint Antidepressant Group by Eli Lilly & Co., and Executive Officer by Neurovance, Inc.
He received his undergraduate degree from Duke University, a graduate degree from Tulane University (Louisiana), and a doctorate degree from Université de Franche-Comté.
Aktive Positionen von Pierre V. Trân
| Unternehmen | Position | Beginn |
|---|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
American Psychiatric Association
 American Psychiatric Association Miscellaneous Commercial ServicesCommercial Services American Psychiatric Association is the largest scientific and professional organization of psychiatrists in the world. The private company is based in Arlington, VA and has subsidiaries in the United States. APA is an organization of psychiatrists working together to ensure humane care and effective treatment for all persons with mental illness, including substance use disorders. Saul Levin has been the CEO of the company since 2013. | Corporate Officer/Principal | - |
| Society of Biological Psychiatry | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Pierre V. Trân
| Unternehmen | Position | Ende |
|---|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | 10.08.2010 |
| XENOPORT, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2007 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.07.2004 |
Neurovance, Inc.
 Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Euthymics Bioscience, Inc.
 Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Pierre V. Trân
| Duke University | Undergraduate Degree |
| Tulane University (Louisiana) | Graduate Degree |
| Université de Franche-Comté | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| RESPIRERX PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Neurovance, Inc.
Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Commercial Services |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
American Psychiatric Association
American Psychiatric Association Miscellaneous Commercial ServicesCommercial Services American Psychiatric Association is the largest scientific and professional organization of psychiatrists in the world. The private company is based in Arlington, VA and has subsidiaries in the United States. APA is an organization of psychiatrists working together to ensure humane care and effective treatment for all persons with mental illness, including substance use disorders. Saul Levin has been the CEO of the company since 2013. | Commercial Services |
| Society of Biological Psychiatry | |
Euthymics Bioscience, Inc.
Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Commercial Services |
